CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Kimia Farma (Persero) Tbk PT Company Snapshot
Kimia Farma (Persero) Tbk PT operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kimia Farma (Persero) Tbk PT with three other pharmaceutical manufacturers in Asia: Luye Pharma Group Limited of Singapore (2016 sales of 605.73 million Singapore Dollars [US$437.35 million] of which 54% was Oncology Drugs), ChangChun High New Technology Industries of China (2.87 billion Chinese Renmimbi [US$417.11 million] of which 81% was Medication), and Hunan ER-KANG Pharmaceutical Co Ltd which is also based in China (2.96 billion Chinese Renmimbi [US$429.74 million] of which 92% was Manufacture of Medicines).

Sales Analysis. Kimia Farma (Persero) Tbk PT reported sales of 5.81 trillion Indonesian Rupiahs (US$436.44 million) for the year ending December of 2016. This represents an increase of 19.6% versus 2015, when the company's sales were 4.86 trillion Indonesian Rupiahs. Sales at Kimia Farma (Persero) Tbk PT have increased during each of the previous five years (and since 2011, sales have increased a total of 67%). Sales of Distribution saw an increase of 32.4% in 2016, from 1.85 trillion Indonesian Rupiahs to 2.45 trillion Indonesian Rupiahs. Not all segments of Kimia Farma (Persero) Tbk PT experienced an increase in sales in 2016: sales of Other fell 3.3% to 87.40 billion Indonesian Rupiahs. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Kimia Farma (Persero) Tbk PT
  Stock Performance Chart for Kimia Farma (Persero) Tbk PT
 
  Stock Data: Recent Stock Performance:
  Current Price (5/26/2017): 2,970.00
(Figures in Indonesian Rupiahs)
1 Week 7.2%   13 Weeks 21.2%  
4 Weeks 63.6%   52 Weeks 148.5%  
 
Kimia Farma (Persero) Tbk PT Key Data:
  Ticker: KAEF Country: Indonesia
  Exchanges: JAK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 5,811,502,656,431
(Year Ending Jan 2017).
Employees: 8,496
  Currency: Indonesian Rupiahs Market Cap: 16,495,380,000,000
  Fiscal Yr Ends: December Shares Outstanding: 5,554,000,000
  Share Type: Series B Closely Held Shares: 5,000,125,000
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.